Deep Genomics the company operates an AI-powered genetic medicine discovery tool with a focus on interpreting genetic variation. Leveraging high-throughput assays and advanced robotics systems, their AI platform generates billions of data points and constructs numerous engineered and validated machine learning systems. These systems play a crucial role in supporting drug development by assisting researchers in classifying, prioritizing, interpreting, and establishing connections among genetic variants, both natural and therapeutic.
$180M • 2021 • Series C
Deep Genomics sees AI taking center stage in medicine, surpassing the complexity of biology beyond human comprehension.
Winning pitch decks that have closed millions in investments for leading startups and billion-dollar unicorns.
Polymateria's Cycle+ technology facilitates advanced biodegradation while preserving the recyclability of various plastic types throughout the product's lifespan. Polymateria raised $19M in 2020 with this deck.
Aurion Biotech is a clinical stage biotech company, developing a transformational platform of advanced therapies to cure blindness. Aurion Biotech raised $120M in 2022 with this deck.
Sano Genetics is a personalised medicine research platform, with a focus on data privacy and transparency. Sano Genetics raised $11M in 2022 with this deck.
PhageLab is a global biotech company that partners with poultry and livestock producers to develop tailor-made antibacterial solutions. PhageLab raised $11M in 2023 with this deck.
ONLY one email per mo (max): the latest in decks & fundraising, curated by a human.